Relationship between pretreatment concentration of plasma Epstein‐Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation

BACKGROUND: Pretreatment plasma Epstein‐Barr virus (EBV) DNA is an important tumor marker and prognostic factor in nasopharyngeal carcinoma (NPC). This study aimed to clarify the relationship between plasma EBV DNA level and tumor burden. MATERIALS AND METHODS: Pretreatment tumor burden was measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Liang, Yang, Yi, Guo, Rui, Mao, Yan‐Ping, Xu, Cheng, Chen, Yu‐Pei, Sun, Ying, Ma, Jun, Tang, Ling‐Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308091/
https://www.ncbi.nlm.nih.gov/pubmed/30378277
http://dx.doi.org/10.1002/cam4.1858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308091/
https://www.ncbi.nlm.nih.gov/pubmed/30378277
http://dx.doi.org/10.1002/cam4.1858

Ejemplares similares